Mesa Laboratories (MLAB) Common Equity (2011 - 2025)

Mesa Laboratories (MLAB) has 15 years of Common Equity data on file, last reported at $186.7 million in Q4 2025.

• Quarterly Common Equity rose 20.28% year-over-year to $186.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $186.7 million (up 20.28% YoY) and the FY2025 annual result came in at $159.8 million, up 9.93% from the prior year.
• Common Equity grew to $186.7 million in Q4 2025 per MLAB's latest filing, from $178.5 million in the prior quarter.
• The five-year high for Common Equity was $406.2 million in Q1 2021, with the low at $145.4 million in Q1 2024.
• Average Common Equity over 5 years is $300.9 million, with a median of $383.8 million recorded in 2022.
• Year-over-year, Common Equity surged 84.64% in 2021 and slumped 63.05% in 2024.
• Mesa Laboratories' Common Equity stood at $396.3 million in 2021, then slipped by 2.3% to $387.2 million in 2022, then advanced by 4.07% to $403.0 million in 2023, then sank by 61.48% to $155.2 million in 2024, then advanced by 20.28% to $186.7 million in 2025.
• Business Quant data shows MLAB's Common Equity at $186.7 million in Q4 2025, $178.5 million in Q3 2025, and $172.5 million in Q2 2025.